DMSA has shown remarkable effectiveness in combatting mercury poisoning by forming strong chelation bonds with mercury, aiding its excretion through the kidneys and bile ducts. It has also demonstrated positive results in reducing levels of lead, bismuth, antimony, and tungsten.

Oral chelation therapy using DMSA has been utilized as an antidote to heavy metal toxicity since the 1950s.

Studies conducted by Adams et al. in 2009 have highlighted the potential benefits of DMSA in reducing inflammation and improving glutathione and platelet levels, particularly in children with Autism Spectrum Disorder (ASD). Moreover, oral DMSA therapy was found to reduce the symptoms of autism spectrum disorder in autistic children. Furthermore, DMSA therapy has been associated with positive outcomes in terms of heavy metal secretion compared to EDTA.

Some sources suggest that DMSA is best and safest used in accordance with the Andy Cutler Chelation protocol, which involves administering the chelator in small, carefully timed doses based on its half-life (every 4 hours), both day and night. Using it any other way is not recommended.

It's essential to emphasize the importance of conducting individual research and consulting a physician before considering any chelation therapy.

Please note that this information is not intended as medical advice. The item is being sold for research and analysis purposes.

CAS number: 304-55-2.